Clinical Trial Update: Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bavituximab in combination with paclitaxel and carboplatin for breast cancer (Stage IV) has completed and reported safety and efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bavituximab (bavituximab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Peregrine Pharmaceuticals | Conditions: Carcinoma Breast Stage IV | Phase 2 | Status: COMPLETED